{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:47:14Z","timestamp":1793296034079,"version":"4.5.0"},"reference-count":134,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.neuroscience.2022.11.001","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T12:05:56Z","timestamp":1668168356000},"page":"139-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Resolvins Lipid Mediators: Potential Therapeutic Targets in Alzheimer and Parkinson Disease"],"prefix":"10.1016","volume":"507","author":[{"given":"Santosh","family":"Anand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Azam Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sambamurthy","family":"Kumaraswamy Sukrutha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad N.","family":"Alomary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anmar","family":"Anwar Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abozer Y.","family":"Elderdery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2022.11.001_b0005","doi-asserted-by":"crossref","first-page":"e75543","DOI":"10.1371\/journal.pone.0075543","article-title":"Spinal actions of lipoxin A4 and 17(R)-resolvin D1 attenuate inflammation-induced mechanical hypersensitivity and spinal TNF release","volume":"8","author":"Abdelmoaty","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0010","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1084\/jem.20042031","article-title":"Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1","volume":"201","author":"Arita","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0015","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.4049\/jimmunol.178.6.3912","article-title":"Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation","volume":"178","author":"Arita","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0020","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.4049\/jimmunol.1502268","article-title":"Resolvin D3 Is Dysregulated in Arthritis and Reduces Arthritic Inflammation","volume":"197","author":"Arnardottir","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0025","article-title":"Sphingosine kinase-dependent regulation of pro-resolving lipid mediators in Alzheimer's disease","volume":"1867","author":"Ayub","year":"2022","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0030","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3390\/ijms21030741","article-title":"Omega-3 Versus Omega-6 Polyunsaturated Fatty Acids in the Prevention and Treatment of Inflammatory Skin Diseases","volume":"21","author":"Bali\u0107","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0035","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0040","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.arcmed.2020.05.002","article-title":"Resolvin D1 Ameliorates Nicotinamide-streptozotocin-induced Type 2 Diabetes Mellitus by its Anti-inflammatory Action and Modulating PI3K\/Akt\/mTOR Pathway in the Brain","volume":"51","author":"Bathina","year":"2020","journal-title":"Arch Med Res"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0045","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.joca.2012.11.012","article-title":"Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!)","volume":"21","author":"Berenbaum","year":"2013","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0050","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.3390\/ijerph16142560","article-title":"The Role of Eicosanoids in Alzheimer's Disease","volume":"16","author":"Biringer","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0055","doi-asserted-by":"crossref","first-page":"6894","DOI":"10.1007\/s12035-018-0889-z","article-title":"Resolvin D1 Halts Remote Neuroinflammation and Improves Functional Recovery after Focal Brain Damage Via ALX\/FPR2 Receptor-Regulated MicroRNAs","volume":"55","author":"Bisicchia","year":"2018","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0060","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.addr.2020.01.004","article-title":"Fatty acid metabolism in the progression and resolution of CNS disorders","volume":"159","author":"Bogie","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"issue":"Suppl 1","key":"10.1016\/j.neuroscience.2022.11.001_b0065","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1017\/S0007114512005119","article-title":"A consideration of biomarkers to be used for evaluation of inflammation in human nutritional studies","volume":"109","author":"Calder","year":"2013","journal-title":"Br J Nutr"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0070","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.3892\/etm.2021.10656","article-title":"Resolvin D2 suppresses NLRP3 inflammasome by promoting autophagy in macrophages","volume":"22","author":"Cao","year":"2021","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0075","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1073\/pnas.79.3.767","article-title":"Cytochrome P-450-dependent oxygenation of arachidonic acid to hydroxyicosatetraenoic acids","volume":"79","author":"Capdevila","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0080","doi-asserted-by":"crossref","first-page":"3267172","DOI":"10.1155\/2020\/3267172","article-title":"Resolution of Inflammation in Neurodegenerative Diseases: The Role of Resolvins","volume":"2020","author":"Chamani","year":"2020","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0085","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.bbi.2020.03.022","article-title":"5-lipoxygenase pathway and its downstream cysteinyl leukotrienes as potential therapeutic targets for Alzheimer's disease","volume":"88","author":"Chen","year":"2020","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0090","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.neuron.2018.11.009","article-title":"Microglia in Pain: Detrimental and Protective Roles in Pathogenesis and Resolution of Pain","volume":"100","author":"Chen","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0095","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1182\/blood.2018886317","article-title":"Resolvin D4 attenuates the severity of pathological thrombosis in mice","volume":"134","author":"Cherpokova","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0100","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature11042","article-title":"Infection regulates pro-resolving mediators that lower antibiotic requirements","volume":"484","author":"Chiang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0105","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.20150225","article-title":"Identification of resolvin D2 receptor mediating resolution of infections and organ protection","volume":"212","author":"Chiang","year":"2015","journal-title":"J Exp Med"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0110","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/jdv.15339","article-title":"Severity, heterogeneity and systemic inflammation in psoriasis","volume":"33","author":"Christophers","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0115","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.ajpath.2016.03.011","article-title":"Resolvin D3 and Aspirin-Triggered Resolvin D3 Are Protective for Injured Epithelia","volume":"186","author":"Colby","year":"2016","journal-title":"Am J Pathol"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.589770","article-title":"Targeting NR4A Nuclear Receptors to Control Stromal Cell Inflammation, Metabolism, Angiogenesis, and Tumorigenesis","volume":"9","author":"Crean","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0125","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.chembiol.2012.11.010","article-title":"Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents","volume":"20","author":"Dalli","year":"2013","journal-title":"Chem Biol"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0130","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.3390\/nu12092751","article-title":"\u03c9-3 and \u03c9-6 Polyunsaturated Fatty Acids, Obesity and Cancer","volume":"12","author":"D'Angelo","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0135","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/ki.2011.32","article-title":"The possible role of ChemR23\/Chemerin axis in the recruitment of dendritic cells in lupus nephritis","volume":"79","author":"De Palma","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0140","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/ijnp\/pyx023","article-title":"Resolvin D1 and D2 Reverse Lipopolysaccharide-Induced Depression-Like Behaviors Through the mTORC1 Signaling Pathway","volume":"20","author":"Deyama","year":"2017","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0145","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.3390\/ijms23073592","article-title":"Specialized Pro-Resolving Lipid Mediators: New Therapeutic Approaches for Vascular Remodeling","volume":"23","author":"Diaz Del Campo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0150","article-title":"Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer's Disease","author":"Do","year":"2022","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0155","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1038\/s41467-021-26516-0","article-title":"Resolvin-D2 targets myogenic cells and improves muscle regeneration in Duchenne muscular dystrophy","volume":"12","author":"Dort","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0160","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000511641","article-title":"Biomarkers of Inflammation in Inflammatory Bowel Disease: How Long before Abandoning Single-Marker Approaches?","volume":"39","author":"Dragoni","year":"2021","journal-title":"Dig Dis"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2022.101165","article-title":"Polyunsaturated fatty acids and fatty acid-derived lipid mediators: Recent advances in the understanding of their biosynthesis, structures, and functions","volume":"86","author":"Dyall","year":"2022","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0170","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.plefa.2017.09.017","article-title":"The role of specialized pro-resolving mediators in maternal-fetal health","volume":"126","author":"Elliott","year":"2017","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0175","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/bpa.12812","article-title":"Schultzberg M. Receptors for pro-resolving mediators are increased in Alzheimer's disease brain","volume":"30","author":"Emre","year":"2020","journal-title":"Brain Pathol"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0180","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1096\/fj.14-264218","article-title":"\u03c9-3 Supplementation increases amyloid-\u03b2 phagocytosis and resolvin D1 in patients with minor cognitive impairment","volume":"29","author":"Fiala","year":"2015","journal-title":"FASEB J"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0185","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1096\/fj.201700065R","article-title":"Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids","volume":"31","author":"Fiala","year":"2017","journal-title":"FASEB J"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0190","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1172\/JCI131609","article-title":"GPR101 mediates the pro-resolving actions of RvD5n-3 DPA in arthritis and infections","volume":"130","author":"Flak","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0195","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.mam.2017.02.003","article-title":"Specialized pro-resolving mediators in cardiovascular diseases","volume":"58","author":"Fredman","year":"2017","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114759","article-title":"Untangling the web of 5-lipoxygenase-derived products from a molecular and structural perspective: The battle between pro- and anti-inflammatory lipid mediators","volume":"193","author":"Gilbert","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0205","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.1073\/pnas.1804000116","article-title":"Aspirin-triggered proresolving mediators stimulate resolution in cancer","volume":"116","author":"Gilligan","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0210","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1073\/pnas.1617290114","article-title":"Protectin D1n\u20133 DPA and resolvin D5n\u20133 DPA are effectors of intestinal protection","volume":"114","author":"Gobbetti","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0215","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/BOR.0b013e328349c2b1","article-title":"Inflammation in osteoarthritis","volume":"23","author":"Goldring","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0220","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.1007\/s12035-021-02500-z","article-title":"Pursuing Multiple Biomarkers for Early Idiopathic Parkinson's Disease Diagnosis","volume":"58","author":"Gopar-Cuevas","year":"2021","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0225","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and Cancer: Triggers, Mechanisms, and Consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0230","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/1753425916628618","article-title":"Resolvin D1, resolvin D2 and maresin 1 activate the GSK3\u03b2 anti-inflammatory axis in TLR4-engaged human monocytes","volume":"22","author":"Gu","year":"2016","journal-title":"Innate Immun"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0235","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.atherosclerosis.2017.05.007","article-title":"The Omega-3 Index and relative risk for coronary heart disease mortality: Estimation from 10 cohort studies","volume":"262","author":"Harris","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0240","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/ATVBAHA.115.305324","article-title":"Resolvin E1 (RvE1) Attenuates Atherosclerotic Plaque Formation in Diet and Inflammation-Induced Atherogenesis","volume":"35","author":"Hasturk","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0245","first-page":"446","article-title":"Role of diets rich in omega-3 and omega-6 in the development of cancer","volume":"73","author":"Huerta-Y\u00e9pez","year":"2016","journal-title":"Bol Med Hosp Infant Mex"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0250","doi-asserted-by":"crossref","first-page":"10525","DOI":"10.1074\/jbc.M112.340612","article-title":"Identification and structure determination of novel anti-inflammatory mediator resolvin E3, 17,18-dihydroxyeicosapentaenoic acid","volume":"287","author":"Isobe","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0255","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.3389\/fphar.2019.01022","article-title":"N-3 Polyunsaturated Fatty Acids and the Resolution of Neuroinflammation","volume":"10","author":"Joffre","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0260","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.expneurol.2017.11.005","article-title":"Combined administration of resolvin E1 and lipoxin A4 resolves inflammation in a murine model of Alzheimer's disease","volume":"300","author":"Kantarci","year":"2018","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0265","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/bs.apcsb.2019.09.004","article-title":"Interplay between inflammation and cancer","volume":"119","author":"Khandia","year":"2020","journal-title":"Adv Protein Chem Struct Biol"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0270","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.addr.2020.07.011","article-title":"Specialized pro-resolving lipid mediators in cardiovascular disease, diagnosis, and therapy","volume":"159","author":"Kim","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0275","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.3390\/ijms23031427","article-title":"GPR18-Mediated Relaxation of Human Isolated Pulmonary Arteries","volume":"23","author":"Koz\u0142owska","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0280","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1038\/s41467-019-11928-w","article-title":"Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's disease","volume":"10","author":"Krashia","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0285","doi-asserted-by":"crossref","first-page":"112656","DOI":"10.1016\/j.biopha.2022.112656","article-title":"Uncoupling proteins as a therapeutic target for the development of new era drugs against neurodegenerative disorder","volume":"147","author":"Kumar","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0290","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJM199009063231006","article-title":"Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases","volume":"323","author":"Lewis","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0295","doi-asserted-by":"crossref","unstructured":"Li F, Eteleeb A, Buchser W, Wang G, Xiong C, Payne PR, McDade E, Karch CM, Harari O, Cruchaga C (2021) Weakly activated core inflammation pathways were identified as a central signaling mechanism contributing to the chronic neurodegeneration in Alzheimer's disease. bioRxiv [Preprint] 2021.08.30.458295.","DOI":"10.1101\/2021.08.30.458295"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0300","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3389\/fphar.2020.00612","article-title":"Role of Resolvins in the Inflammatory Resolution of Neurological Diseases","volume":"11","author":"Li","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0305","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3390\/biom11060789","article-title":"The Roles of Various Prostaglandins in Fibrosis: A Review","volume":"11","author":"Li","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0310","doi-asserted-by":"crossref","first-page":"6965","DOI":"10.3390\/ijms22136965","article-title":"Effects of Dietary n-3 and n-6 Polyunsaturated Fatty Acids in Inflammation and Cancerogenesis","volume":"22","author":"Liput","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0315","first-page":"60","article-title":"Neuronal phagocytosis by inflammatory macrophages in ALS spinal cord: inhibition of inflammation by resolvin D1","volume":"1","author":"Liu","year":"2012","journal-title":"Am J Neurodegener Dis"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0320","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41698-020-00138-z","article-title":"Microbiome dysbiosis in lung cancer: from composition to therapy","volume":"4","author":"Liu","year":"2020","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0325","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1007\/s12035-020-02237-1","article-title":"Resolvin D1 Attenuates Innate Immune Reactions in Experimental Subarachnoid Hemorrhage Rat Model","volume":"58","author":"Liu","year":"2021","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0330","doi-asserted-by":"crossref","first-page":"9590","DOI":"10.1523\/JNEUROSCI.0020-16.2016","article-title":"Resolvin D1 Programs Inflammation Resolution by Increasing TGF-\u03b2 Expression Induced by Dying Cell Clearance in Experimental Autoimmune Neuritis","volume":"36","author":"Luo","year":"2016","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0335","doi-asserted-by":"crossref","first-page":"e13393","DOI":"10.1111\/acel.13393","article-title":"Metabolipidomic profiling reveals an age-related deficiency of skeletal muscle pro-resolving mediators that contributes to maladaptive tissue remodeling","volume":"20","author":"Markworth","year":"2021","journal-title":"Aging Cell"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0340","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.3390\/ijms21103624","article-title":"Nutraceuticals Targeting Generation and Oxidant Activity of Peroxynitrite May Aid Prevention and Control of Parkinson's Disease","volume":"21","author":"McCarty","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0345","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature07201","article-title":"Origin and physiological roles of inflammation","volume":"454","author":"Medzhitov","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0350","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.617588","article-title":"Mitochondrial Dysfunction and Oxidative Stress in Alzheimer's Disease","volume":"13","author":"Misrani","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0355","doi-asserted-by":"crossref","first-page":"5783","DOI":"10.3390\/ijms21165783","article-title":"Alzheimer's Disease and Specialized Pro-Resolving Lipid Mediators: Do MaR1, RvD1, and NPD1 Show Promise for Prevention and Treatment?","volume":"21","author":"Miyazawa","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174527","article-title":"Resolvin D1, therapeutic target in acute respiratory distress syndrome","volume":"911","author":"Molaei","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0365","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0090-6980(02)00029-1","article-title":"Distinct functions of COX-1 and COX-2","volume":"68\u201369","author":"Morita","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0370","doi-asserted-by":"crossref","first-page":"e94463","DOI":"10.1172\/jci.insight.94463","article-title":"Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli-driven acute inflammation","volume":"3","author":"Motwani","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0375","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI200113455","article-title":"Genetic and pharmacological analysis of prostanoid receptor function","volume":"108","author":"Narumiya","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0380","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.plefa.2016.01.001","article-title":"Resolvin D3 multi-level proresolving actions are host protective during infection","volume":"138","author":"Norris","year":"2018","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"10","key":"10.1016\/j.neuroscience.2022.11.001_b0385","doi-asserted-by":"crossref","first-page":"eaax4895","DOI":"10.1126\/sciadv.aax4895","article-title":"Resolution metabolomes activated by hypoxic environment","volume":"5","author":"Norris","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0390","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1111\/bph.13331","article-title":"Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?","volume":"172","author":"O'Callaghan","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0395","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1248\/bpb.b22-00370","article-title":"Prostacyclin Synthase as an Ambivalent Regulator of Inflammatory Reactions","volume":"45","author":"Ochiai","year":"2022","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0400","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3389\/fnmol.2017.00242","article-title":"Peripheral Interaction of Resolvin D1 and E1 with Opioid Receptor Antagonists for Antinociception in Inflammatory Pain in Rats","volume":"10","author":"Oehler","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0405","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1172\/JCI42545","article-title":"Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation","volume":"121","author":"Oh","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0410","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.4049\/jimmunol.1103652","article-title":"Resolvin E2 formation and impact in inflammation resolution","volume":"188","author":"Oh","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0415","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1074\/jbc.M109.044131","article-title":"Resolvin E1 receptor activation signals phosphorylation and phagocytosis","volume":"285","author":"Ohira","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0420","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/ajcn\/nqz016","article-title":"Plasma oxylipins respond in a linear dose-response manner with increased intake of EPA and DHA: results from a randomized controlled trial in healthy humans","volume":"109","author":"Ostermann","year":"2019","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0425","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.3390\/cells10112903","article-title":"Dissecting the Crosstalk between Endothelial Mitochondrial Damage, Vascular Inflammation, and Neurodegeneration in Cerebral Amyloid Angiopathy and Alzheimer's Disease","volume":"10","author":"Parodi-Rull\u00e1n","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0430","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3389\/fphar.2018.01273","article-title":"Lipoxin and Resolvin Receptors Transducing the Resolution of Inflammation in Cardiovascular Disease","volume":"9","author":"Pirault","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113930","article-title":"Targeting the OXE receptor as a potential novel therapy for asthma","volume":"179","author":"Powell","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0440","doi-asserted-by":"crossref","first-page":"9477","DOI":"10.1073\/pnas.1921335117","article-title":"Resolvin E1 is a pro-repair molecule that promotes intestinal epithelial wound healing","volume":"117","author":"Quiros","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0445","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1124\/mi.6.4.6","article-title":"COX-2 in inflammation and resolution","volume":"6","author":"Rajakariar","year":"2006","journal-title":"Mol Interv"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0450","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1172\/JCI89429","article-title":"Accelerated resolution of inflammation underlies sex differences in inflammatory responses in humans","volume":"127","author":"Rathod","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0455","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1096\/fj.10-169599","article-title":"MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits","volume":"25","author":"Recchiuti","year":"2011","journal-title":"FASEB J"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0460","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/jnc.14962","article-title":"Resolvin D1 ameliorates cognitive impairment following traumatic brain injury via protecting astrocytic mitochondria","volume":"154","author":"Ren","year":"2020","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0465","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1161\/CIRCRESAHA.121.319077","article-title":"Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease","volume":"128","author":"Ridker","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0470","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000430343","article-title":"The Adipokine Chemerin Induces Apoptosis in Cardiomyocytes","volume":"37","author":"Rodr\u00edguez-Penas","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0475","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1053\/j.gastro.2015.07.003","article-title":"Biomarkers of Inflammation in Inflammatory Bowel Disease","volume":"149","author":"Sands","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0480","doi-asserted-by":"crossref","first-page":"12750","DOI":"10.1096\/fj.201900283R","article-title":"Resolvin E3 attenuates allergic airway inflammation via the interleukin-23-interleukin-17A pathway","volume":"33","author":"Sato","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0485","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1084\/jem.20150381","article-title":"Resolvin E1 inhibits dendritic cell migration in the skin and attenuates contact hypersensitivity responses","volume":"212","author":"Sawada","year":"2015","journal-title":"J Exp Med"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0490","first-page":"1","article-title":"Effects of omega-3 fatty acids on mental health","volume":"116","author":"Schachter","year":"2005","journal-title":"Evid Rep Technol Assess (Summ)"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0495","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.plefa.2003.07.003","article-title":"COX-3 the enzyme and the concept: steps towards highly specialized pathways and precision therapeutics?","volume":"69","author":"Schwab","year":"2003","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0500","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0505","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1172\/JCI97943","article-title":"Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators","volume":"128","author":"Serhan","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0510","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1021\/cr100396c","article-title":"Resolvins and protectins in inflammation resolution","volume":"111","author":"Serhan","year":"2011","journal-title":"Chem Rev"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0515","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1096\/fj.06-7227rev","article-title":"Resolution of inflammation: state of the art, definitions and terms","volume":"21","author":"Serhan","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0520","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.coph.2013.05.012","article-title":"Resolution phase lipid mediators of inflammation: agonists of resolution","volume":"13","author":"Serhan","year":"2013","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0525","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/joim.12871","article-title":"Novel mediators and mechanisms in the resolution of infectious inflammation: evidence for vagus regulation","volume":"286","author":"Serhan","year":"2019","journal-title":"J Intern Med"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0530","article-title":"E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition","volume":"16","author":"Serhan","year":"2022","journal-title":"Semin Immunol"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0535","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1080\/14728222.2019.1691525","article-title":"Inflammation resolution and specialized pro-resolving lipid mediators in CNS diseases","volume":"23","author":"Shang","year":"2019","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0540","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1073\/pnas.83.12.4175","article-title":"Characterization of leukotriene A4 synthase from murine mast cells: evidence for its identity to arachidonate 5-lipoxygenase","volume":"83","author":"Shimizu","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0545","doi-asserted-by":"crossref","first-page":"560S","DOI":"10.1093\/ajcn\/70.3.560s","article-title":"Essential fatty acids in health and chronic disease","volume":"70","author":"Simopoulos","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0550","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0753-3322(02)00253-6","article-title":"The importance of the ratio of omega-6\/omega-3 essential fatty acids","volume":"56","author":"Simopoulos","year":"2002","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0555","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/nu8030128","article-title":"An Increase in the Omega-6\/Omega-3 Fatty Acid Ratio Increases the Risk for Obesity","volume":"8","author":"Simopoulos","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0560","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/aam.aam_56_18","article-title":"Inflammation and cancer","volume":"18","author":"Singh","year":"2019","journal-title":"Ann Afr Med"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0565","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.3390\/nu10101561","article-title":"Polyunsaturated Fatty Acids and Their Potential Therapeutic Role in Cardiovascular System Disorders-A Review","volume":"10","author":"Soko\u0142a-Wysocza\u0144ska","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0570","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-3-030-33330-0_7","article-title":"Inflammation, Frailty and Cardiovascular Disease","volume":"1216","author":"Soysal","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0575","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/imr.12839","article-title":"Inflammasomes contributing to inflammation in arthritis","volume":"294","author":"Spel","year":"2020","journal-title":"Immunol Rev"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0580","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/CIRCRESAHA.110.223883","article-title":"Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins","volume":"107","author":"Spite","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0585","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41569-021-00552-1","article-title":"Interplay between inflammation and thrombosis in cardiovascular pathology","volume":"18","author":"Stark","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0590","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.3390\/ijms23084457","article-title":"Psoriasis and Systemic Inflammatory Disorders","volume":"23","author":"Tashiro","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.neuroscience.2022.11.001_b0595","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.bbrc.2015.03.109","article-title":"Resolvin D2 recovers neural injury by suppressing inflammatory mediators expression in lipopolysaccharide-induced Parkinson's disease rat model","volume":"460","author":"Tian","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0600","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.4049\/jimmunol.1100225","article-title":"Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype","volume":"187","author":"Titos","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0605","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.3390\/ijms22063119","article-title":"Cross-Talk among Polymorphonuclear Neutrophils, Immune, and Non-Immune Cells via Released Cytokines, Granule Proteins, Microvesicles, and Neutrophil Extracellular Trap Formation: A Novel Concept of Biology and Pathobiology for Neutrophils","volume":"22","author":"Tsai","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0610","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.3390\/molecules27154836","article-title":"Specialized Pro-Resolving Mediators in Neuroinflammation: Overview of Studies and Perspectives of Clinical Applications","volume":"27","author":"Valente","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0615","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.plefa.2018.11.013","article-title":"Combined administration of docosahexaenoic acid and thyroid hormone synergistically enhances rat liver levels of resolvins RvD1 and RvD2","volume":"140","author":"Videla","year":"2019","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0620","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.3390\/cells11111732","article-title":"Alpha-Synuclein Aggregation Pathway in Parkinson's Disease: Current Status and Novel Therapeutic Approaches","volume":"11","author":"Vidovi\u0107","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0625","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1182\/blood.2021014699","article-title":"Neutrophil dysfunction in the pathogenesis of cystic fibrosis","volume":"139","author":"Wang","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0630","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","article-title":"Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0635","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1124\/pr.110.003517","article-title":"International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress","volume":"63","author":"Woodward","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0640","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.joen.2019.05.005","article-title":"Resolvin E1 Ameliorates Pulpitis by Suppressing Dental Pulp Fibroblast Activation in a Chemerin Receptor 23-dependent Manner","volume":"45","author":"Xu","year":"2019","journal-title":"J Endod"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0645","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.12659\/MSM.901995","article-title":"Resolvin D1 Attenuates Mpp+-Induced Parkinson Disease via Inhibiting Inflammation in PC12 Cells","volume":"23","author":"Xu","year":"2017","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0650","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12931-021-01792-y","article-title":"Role of specialized pro-resolving lipid mediators in pulmonary inflammation diseases: mechanisms and development","volume":"22","author":"Yang","year":"2021","journal-title":"Respir Res"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0655","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.osfp.2013.01.003","article-title":"An evidence-based osteopathic approach to Parkinson disease","volume":"5","author":"Yao","year":"2013","journal-title":"Osteopath Fam Physician"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0660","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.brainres.2016.10.006","article-title":"Expression and cell distribution of leukotriene B4 receptor 1 in the rat brain cortex after experimental subarachnoid hemorrhage","volume":"1652","author":"Ye","year":"2016","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0665","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/jb\/mvu078","article-title":"Two distinct leukotriene B4 receptors, BLT1 and BLT2","volume":"157","author":"Yokomizo","year":"2015","journal-title":"J Biochem"},{"key":"10.1016\/j.neuroscience.2022.11.001_b0670","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/978-3-030-68748-9_11","article-title":"Redox Role of ROS and Inflammation in Pulmonary Diseases","volume":"1304","author":"Zuo","year":"2021","journal-title":"Adv Exp Med Biol"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452222005462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452222005462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:16:10Z","timestamp":1759680970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452222005462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":134,"alternative-id":["S0306452222005462"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2022.11.001","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resolvins Lipid Mediators: Potential Therapeutic Targets in Alzheimer and Parkinson Disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2022.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 IBRO. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}